Array BioPharma Slaps $192M Lawsuit on AstraZeneca Over Cancer Drug Royalties Post author:Sam Post published:February 1, 2018 Post category:BioPharma AstraZeneca did not immediately respond to a request for comment. Source: BioSpace You Might Also Like Roche Gets in on Bay Area Allakos' $100M Funding Round December 12, 2017 How Biogen Lost Its Chance to Be the Hunter and Became the Hunted in Just a Few Months April 16, 2017 26-Employee Cue BioPharma Seeks $40 Million IPO Eight Months After Emerging From Stealth Mode September 25, 2017
How Biogen Lost Its Chance to Be the Hunter and Became the Hunted in Just a Few Months April 16, 2017
26-Employee Cue BioPharma Seeks $40 Million IPO Eight Months After Emerging From Stealth Mode September 25, 2017
